Cabana trial pdf
Rating: 4.8 / 5 (4214 votes)
Downloads: 18572
CLICK HERE TO DOWNLOAD
DOI: Open Access. drug therapy on cardiovascular outcomes ‒Explaining the CABANA design & issues ‒Examining the Intention-to-treat & Despite mxed reactions among the cardiovascular com-munity, the recently published Catheter ABlation vs ANtiarrhythmic Drug Therapy in Atrial Fibrillation (CABANA) trial subgroup analysis of of the patients randomized in the CABANA (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation) trialwho had HF Download PDFPerspectives in Cardiology. Overview. METHODS: The CABANA trial randomized patients with AF who were ≥years old or Explaining the CABANA Trial. Science deserves justice: The results of the CABANA trial are positive and Catheter ablation in CABANA trial patients with AF and class II or greater HF produced clinically consequential reductions in all-cause mortality (43% relative reduction, per absolute reduction atyears), as well as a lower AF recurrence rates (44% reduction in time to first recurrence) and AF burden Two reports in JAMA detail findings from the CABANA trial, a randomized, open-label trial comparing the effects of drug therapy vs cardiac catheter ablation on a composite outcome of death, disabling stroke, serious bleeding, or cardiac arrest in patients with symptomatic atrial fibrillation In this international, investigator-initiated, parallel-group, open, blinded-outcome-assessment trial, we randomly assigned patients who had early atrial fibrillation (diagnosed ≤1 year before CONCLUSIONS: In patients with AF enrolled in the CABANA trial who had clinically diagnosed stable heart failure at trial entry, catheter ablation produced clinically important improvements in survival, freedom from AF recurrence, and quality of life relative to drug therapy CASTLE-AF is a multicenter, open-label, randomized, controlled trial that was conducted to assess whether catheter ablation lowers morbidity and mortality as compared with medical therapy (rate •Ablation vs.